133 related articles for article (PubMed ID: 30544927)
1. Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases.
Roura Padrosa D; Castro J; Romero-Casañas A; Ribó M; Vilanova M; Benito A
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544927
[TBL] [Abstract][Full Text] [Related]
2. Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
Vert A; Castro J; Ruiz-Martínez S; Tubert P; Escribano D; Ribó M; Vilanova M; Benito A
Mol Pharm; 2012 Oct; 9(10):2894-902. PubMed ID: 22957849
[TBL] [Abstract][Full Text] [Related]
3. Increased proteolytic resistance of ribonuclease A by protein engineering.
Markert Y; Köditz J; Mansfeld J; Arnold U; Ulbrich-Hofmann R
Protein Eng; 2001 Oct; 14(10):791-6. PubMed ID: 11739898
[TBL] [Abstract][Full Text] [Related]
4. Endowing human pancreatic ribonuclease with toxicity for cancer cells.
Leland PA; Staniszewski KE; Kim BM; Raines RT
J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655
[TBL] [Abstract][Full Text] [Related]
5. The effect of additional disulfide bonds on the stability and folding of ribonuclease A.
Pecher P; Arnold U
Biophys Chem; 2009 Apr; 141(1):21-8. PubMed ID: 19155118
[TBL] [Abstract][Full Text] [Related]
6. A nuclear localization sequence endows human pancreatic ribonuclease with cytotoxic activity.
Bosch M; Benito A; Ribó M; Puig T; Beaumelle B; Vilanova M
Biochemistry; 2004 Mar; 43(8):2167-77. PubMed ID: 14979713
[TBL] [Abstract][Full Text] [Related]
7. Conformational stability is a determinant of ribonuclease A cytotoxicity.
Klink TA; Raines RT
J Biol Chem; 2000 Jun; 275(23):17463-7. PubMed ID: 10747991
[TBL] [Abstract][Full Text] [Related]
8. Disruption of shape-complementarity markers to create cytotoxic variants of ribonuclease A.
Rutkoski TJ; Kurten EL; Mitchell JC; Raines RT
J Mol Biol; 2005 Nov; 354(1):41-54. PubMed ID: 16188273
[TBL] [Abstract][Full Text] [Related]
9. Valine 108, a chain-folding initiation site-belonging residue, crucial for the ribonuclease A stability.
Coll MG; Protasevich II; Torrent J; Ribó M; Lobachov VM; Makarov AA; Vilanova M
Biochem Biophys Res Commun; 1999 Nov; 265(2):356-60. PubMed ID: 10558871
[TBL] [Abstract][Full Text] [Related]
10. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
[TBL] [Abstract][Full Text] [Related]
11. Increasing the potency of a cytotoxin with an arginine graft.
Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
[TBL] [Abstract][Full Text] [Related]
12. A ribonuclease inhibitor resistant dimer of human pancreatic ribonuclease displays specific antitumor activity.
Attery A; Dey P; Tripathi P; Batra JK
Int J Biol Macromol; 2018 Feb; 107(Pt B):1965-1970. PubMed ID: 29042278
[TBL] [Abstract][Full Text] [Related]
13. Compensating effects on the cytotoxicity of ribonuclease A variants.
Dickson KA; Dahlberg CL; Raines RT
Arch Biochem Biophys; 2003 Jul; 415(2):172-7. PubMed ID: 12831839
[TBL] [Abstract][Full Text] [Related]
14. Rational design and evaluation of mammalian ribonuclease cytotoxins.
Lomax JE; Eller CH; Raines RT
Methods Enzymol; 2012; 502():273-90. PubMed ID: 22208989
[TBL] [Abstract][Full Text] [Related]
15. Production of engineered human pancreatic ribonucleases, solving expression and purification problems, and enhancing thermostability.
Canals A; Ribó M; Benito A; Bosch M; Mombelli E; Vilanova M
Protein Expr Purif; 1999 Oct; 17(1):169-81. PubMed ID: 10497083
[TBL] [Abstract][Full Text] [Related]
16. Dissimilarity in the reductive unfolding pathways of two ribonuclease homologues.
Narayan M; Xu G; Ripoll DR; Zhai H; Breuker K; Wanjalla C; Leung HJ; Navon A; Welker E; McLafferty FW; Scheraga HA
J Mol Biol; 2004 May; 338(4):795-809. PubMed ID: 15099746
[TBL] [Abstract][Full Text] [Related]
17. Disulfide bonds elimination of endoglucanase II from Trichoderma reesei by site-directed mutagenesis to improve enzyme activity and thermal stability: An experimental and theoretical approach.
Akbarzadeh A; Pourzardosht N; Dehnavi E; Ranaei Siadat SO; Zamani MR; Motallebi M; Nikzad Jamnani F; Aghaeepoor M; Barshan Tashnizi M
Int J Biol Macromol; 2018 Dec; 120(Pt B):1572-1580. PubMed ID: 30267817
[TBL] [Abstract][Full Text] [Related]
18. New muteins of RNase A with enhanced antitumor action.
Cafaro V; Bracale A; Di Maro A; Sorrentino S; D'Alessio G; Di Donato A
FEBS Lett; 1998 Oct; 437(1-2):149-52. PubMed ID: 9804190
[TBL] [Abstract][Full Text] [Related]
19. Significant stabilization of ribonuclease A by additive effects.
Arnold U; Schöpfel M
FEBS J; 2012 Jul; 279(14):2508-19. PubMed ID: 22594773
[TBL] [Abstract][Full Text] [Related]
20. Kinetic folding pathway of a three-disulfide mutant of bovine pancreatic ribonuclease A missing the [40-95] disulfide bond.
Xu X; Scheraga HA
Biochemistry; 1998 May; 37(20):7561-71. PubMed ID: 9585571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
